06:48:04 Europe / Stockholm
Svenska | English

Mentice

Attachments

Share price & Turnover

Share price change and turnover during the day of this press release

Subscription

Calendar

2024-11-07 Quarterly Report 2024-Q3
2024-07-23 Quarterly Report 2024-Q2
2024-05-24 Ex-date Ordinary Dividend MNTC 0.00 SEK
2024-05-23 Annual General meeting
2024-05-03 Quarterly Report 2024-Q1
2024-02-15 Year-end Report 2023
2023-10-26 Quarterly Report 2023-Q3
2023-07-20 Quarterly Report 2023-Q2
2023-05-12 Ex-date Ordinary Dividend MNTC 0.00 SEK
2023-05-11 Annual General meeting
2023-04-27 Quarterly Report 2023-Q1
2023-02-03 Year-end Report 2022
2022-10-26 Quarterly Report 2022-Q3
2022-07-21 Quarterly Report 2022-Q2
2022-04-28 Quarterly Report 2022-Q1
2022-04-28 Ex-date Ordinary Dividend MNTC 0.00 SEK
2022-04-27 Annual General meeting
2022-02-03 Year-end Report 2021
2021-10-28 Quarterly Report 2021-Q3
2021-07-22 Quarterly Report 2021-Q2
2021-05-07 Ex-date Ordinary Dividend MNTC 0.00 SEK
2021-05-06 Annual General meeting
2021-04-28 Quarterly Report 2021-Q1
2021-02-04 Year-end Report 2020
2020-11-12 Quarterly Report 2020-Q3
2020-08-13 Quarterly Report 2020-Q2
2020-05-28 Ex-date Ordinary Dividend MNTC 0.00 SEK
2020-05-27 Annual General meeting
2020-05-14 Quarterly Report 2020-Q1
2020-02-27 Year-end Report 2019
2019-11-25 Quarterly Report 2019-Q3
2019-08-29 Quarterly Report 2019-Q2
2019-08-28 Extra General Meeting 2019

Description

CountrySweden
ListFirst North Stockholm
SectorHealth care
IndustryMedical technology
Mentice är verksamt inom medicinteknik. Bolaget utvecklar medicinska instrument för endovaskulär simulering samt för träningstillfällen inom kirurgi. Programmen är utvecklade för att användas i utbildningssyfte bland sjukhus och institut. Störst verksamhet återfinns inom Nordamerika och Europa. Utöver huvudverksamheten erbjuds möjligheter till leasing, support, samt teknisk service. Huvudkontoret ligger i Göteborg.
Correction: Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.
2023-07-07 13:54:00

Correction made to previous reference to EU Market Abuse Regulation

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.

The presentation of the Q2-2023 interim report for the period April – June 2023 will be held on July 20 at 10:00 CEST. Redeye's equity analyst Christian Binder will host the live broadcast and moderate the Q&A.

For more information on how to register, please visit https://investor.mentice.com/.

The presentation will be held in English. Participants are advised to register in advance.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.

Source MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

An email has been sent to the given address. To login please click "Login" in that email to verify your account

Companies

Press releases